Earnings Call · Q1 FY2021·2021-05-06

Q1 21EPS +1.91%·Rev n/aQ4 20EPS -34.83%·Rev n/aQ3 20EPS -1.43%·Rev n/aQ2 20EPS -15.27%·Rev n/a⚠ consensus missing

Sarepta Therapeutics, Inc. SRPT

Mary Jenkins — Senior Management, Investor Relations

Douglas Ingram — Chief Executive Officer (CEO)

Ian Estepan — Finance or Investor Relations (context suggests financial reporting)

Dallan Murray — Senior Management or Executive (context suggests leadership role)

Gilmore O'Neill — Medical or Scientific Officer (likely Chief Medical Officer)

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SRPT calls or request research access.

More SRPT calls Browse calls Request research access